Lps

Manulife buying infra CVs, secondaries to address low DPI

Rising retail flows offer a new exit route for infra assets, but they also create their own issues, infrastructure fund investment head Kate Roscoe tells Secondaries Investor.

Japanese LPs find credit secondaries a challenging prospect

‘Asymmetry’ of information and lack of look-through are preventing some investors from participating, according to speakers at PEI Group’s Private Debt Investor Tokyo Forum.

LPs look to blindpool fund side letters for more visibility on CVs: Morgan Lewis – updated

Some LPs are finding themselves as forced sellers in CVs because of the length of time given in election periods.

Secondaries becoming a fixture of managing capital for Partners Capital’s LP clients

Even though some return mechanisms secondaries buyers have historically looked to are less attractive in today’s market, the OCIO firm is encouraging its clients to participate in the growing secondaries market both as a buyer and to reshape its programmes as a seller.

How we conducted Secondaries Investor’s Global Market Survey

Our inaugural survey takes the temperature of LP, GP, buyer and provider attitudes towards this fast-growing market.

LP activity intensifies in rush for liquidity

A distribution desert has led to a surge in first-time LP sellers, while a challenged fundraising market has heralded the return of the primary staple.

Lexington leads MetLife’s $1bn managed fund deal

The insurer worked with Evercore to shop a $1.8bn portfolio under the name Project Trident, Secondaries Investor has learned.

Credit secondaries gains traction among Korean LPs

A growing number of LPs in South Korea see secondaries as an opportunity to invest in credit at a low price with downside protection.

Samsung Asset Management eyes credit secondaries, co-investments

Such opportunities ‘can provide us with some downside protection against the macro flows rather than going with the flow as part of the herd’, says head and OCIO Seong Sup Cho.

China’s Ping An Insurance explores circa $1bn portfolio sale

This is at least the sixth time the insurance giant has run a secondaries process.